You are not allowed to view Ad
Important pharmacy news and late-breaking industry information updated daily.
FDA announced Monday that it has approved nine applications for the generic versions of pregabalin (Lyrica—Pfizer) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients aged 17 years a
Oklahoma's $17 billion lawsuit against Johnson & Johnson and its Janssen Pharmaceuticals subsidiary is now in the hands of Cleveland County District Judge Thad Balkman.
U.S. District Court Judge Amit Mehta on Monday ruled the Trump administration overstepped its authority with a rule to force drug companies to include the price of their medicine in television advertisements.
Twenty companies raised the list prices of more than 40 prescription drugs by an average of 13.1% on Monday, according to Rx Savings Solutions. On July 1 last year, 16 companies raised the list prices of dozens of drugs by an average 7.8%. Drug companies had typically raised list prices at the start of the year and again 6 months later.
President Donald Trump on Monday signed an executive order intended to give Americans more information about the cost and quality of health care services to help them comparison shop before they get care.
FDA on Monday approved liraglutide (Victoza—Novo Nordisk) injection for the treatment of pediatric patients aged 10 years or older with types 2 diabetes. The non-insulin drug has been approved to treat adults with type 2 diabetes for nearly a decade.
APhA and other pharmacy organizations on Monday sent a letter to President Donald Trump calling on his administration to provide relief from pharmacy direct and indirect remuneration (DIR) fees that inflate drug costs paid by patients and the government, and that force pharmacies to fill Medicare prescriptions often below cost.
CDC reported Thursday that the number of measles cases recorded so far this year hit 971, a figure exceeding a high set in 1992, when 963 cases were recorded in the entire year.
Gov. Kevin Stitt of Oklahoma on Tuesday signed a revised pharmacy choice bill into law, 3 weeks after vetoing an earlier version. House Bill 2632 prohibits restrictions on a patient's right to choose a pharmacy provider without paying a penalty and calls for an advisory committee to review complaints and administer fines.
Attorneys general from more than 40 states filed a lawsuit in federal court in Connecticut on Friday, alleging the nation's largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs.